Kui Wang

4.2k total citations · 3 hit papers
72 papers, 2.9k citations indexed

About

Kui Wang is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Kui Wang has authored 72 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 30 papers in Hepatology and 28 papers in Oncology. Recurrent topics in Kui Wang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (28 papers) and Pancreatic and Hepatic Oncology Research (13 papers). Kui Wang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (28 papers) and Pancreatic and Hepatic Oncology Research (13 papers). Kui Wang collaborates with scholars based in China, Hong Kong and United States. Kui Wang's co-authors include Yong Xia, Feng Shen, Mengchao Wu, Xuying Wan, Dong Wu, Zhenlin Yan, Jun Li, Lehua Shi, Wan Yee Lau and Anfeng Si and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Kui Wang

64 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

2013 839 citations Yizhou Wang, Jun Li et al. Journal of Clinical Oncology profile →
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria

2015 458 citations Zhengqing Lei, Jun Li et al. profile →
Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription

2021 171 citations Qinjunjie Chen, Haibo Wang et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kui Wang China	25	1.3k	1.1k	866	864	641	72	2.9k
Daniel M. Labow United States	27	1.8k 1.4×	1.2k 1.1×	1.2k 1.3×	878 1.0×	320 0.5×	102	3.1k
Jordi Muchart Spain	20	834 0.7×	2.4k 2.1×	373 0.4×	672 0.8×	355 0.6×	73	3.8k
Piotr Czauderna Poland	30	1.8k 1.4×	2.4k 2.1×	1.4k 1.6×	536 0.6×	621 1.0×	108	4.1k
Tatsuya Ioka Japan	29	1.3k 1.0×	263 0.2×	2.1k 2.4×	1.0k 1.2×	624 1.0×	166	3.0k
Dieter Koeberle Switzerland	23	562 0.4×	306 0.3×	1.6k 1.9×	739 0.9×	430 0.7×	87	2.3k
Ahmet Ayav France	28	1.8k 1.4×	659 0.6×	843 1.0×	546 0.6×	179 0.3×	107	2.7k
Magnus Rizell Sweden	26	740 0.6×	783 0.7×	533 0.6×	360 0.4×	76 0.1×	92	1.9k
Toshiaki Tanaka Japan	30	1.3k 1.0×	139 0.1×	1.9k 2.2×	723 0.8×	378 0.6×	217	3.3k
Giuseppe Nigri Italy	32	2.0k 1.5×	163 0.1×	1.7k 2.0×	1.0k 1.2×	218 0.3×	147	3.2k
Giuseppe Fusai United Kingdom	31	1.2k 0.9×	740 0.6×	1.2k 1.3×	578 0.7×	111 0.2×	71	2.6k

Countries citing papers authored by Kui Wang

Since Specialization

Citations

This map shows the geographic impact of Kui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Wang more than expected).

Fields of papers citing papers by Kui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Wang. The network helps show where Kui Wang may publish in the future.

Co-authorship network of co-authors of Kui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kui Wang. A scholar is included among the top collaborators of Kui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kui Wang. Kui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Xiaoxin, et al.. (2025). Integrative habitat analysis and multi-instance deep learning for predictive model of PD-1/PD-L1 immunotherapy efficacy in NSCLC patients: a dual-center retrospective study. BMC Medical Imaging. 25(1). 288–288.

Huang, Xiaoxin, et al.. (2025). Predictors of occult lymph node metastasis in clinical T1 lung adenocarcinoma: a retrospective dual-center study. BMC Pulmonary Medicine. 25(1). 99–99.

Sun, Hui‐Chuan, Xiaodong Zhu, Kui Wang, et al.. (2024). Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: A single-arm, multi-center, phase II trial (NeoLEAP-HCC).. Journal of Clinical Oncology. 42(16_suppl). 4120–4120. 3 indexed citations

Wang, Kui, Jiawei Wang, Yuhua Chen, et al.. (2024). Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study. Aging. 16(4). 3596–3611. 11 indexed citations

Zong, Chen, Hui Xue, Yao Li, et al.. (2024). YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis. The Journal of Gene Medicine. 26(5). e3689–e3689. 4 indexed citations

Huang, Xinping, Kui Wang, Renkai Wu, et al.. (2024). Neoadjuvant Chemotherapy plus Tislelizumab Followed by Adjuvant Tislelizumab for Locoregionally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). e791–e791. 1 indexed citations

Shi, Xiaodong, et al.. (2024). The preoperative scoring system combining neutrophil/lymphocyte ratio and CA19-9 predicts the long-term prognosis of intrahepatic cholangiocarcinoma patients undergoing curative liver resection. BMC Cancer. 24(1). 1106–1106. 4 indexed citations

Wang, Kui, Yifei Chen, Yuhua Chen, et al.. (2024). The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis. Frontiers in Cellular and Infection Microbiology. 14. 1308742–1308742. 16 indexed citations

Liu, Jianwei, Yong Xia, Caixia Lü, et al.. (2023). The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion. The Oncologist. 28(11). e1043–e1051. 12 indexed citations

10.

Zhao, Yang, Jianwei Liu, Feng Xue, et al.. (2023). Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of Hepatology. 28(2). 100898–100898. 3 indexed citations

11.

Yang, Man, Jieshuang Jia, Hui Yao, et al.. (2022). CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression. Cellular Signalling. 93. 110270–110270. 6 indexed citations

12.

Chen, Qinjunjie, Haibo Wang, Zheng Li, et al.. (2021). Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. Journal of Hepatology. 76(1). 135–147. 171 indexed citations breakdown →

13.

Peng, Hao, Rong Huang, Kui Wang, et al.. (2020). Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors. Journal of Molecular Diagnostics. 23(2). 223–233. 8 indexed citations

14.

Lei, Zhengqing, Yong Xia, Anfeng Si, et al.. (2017). Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection. Journal of Hepatology. 68(4). 655–662. 30 indexed citations

15.

Wang, Qing, Jun Li, Zhengqing Lei, et al.. (2017). Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis. Annals of Surgical Oncology. 24(6). 1579–1587. 31 indexed citations

16.

Li, Jun, Jian Zhou, Pinghua Yang, et al.. (2016). Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. European Journal of Cancer. 62. 86–95. 42 indexed citations

17.

Zou, Qifei, Jun Li, Dong Wu, et al.. (2016). Nomograms for Pre-operative and Post-operative Prediction of Long-Term Survival of Patients Who Underwent Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma. Annals of Surgical Oncology. 23(8). 2618–2626. 37 indexed citations

18.

Yang, Xinwei, Kui Wang, Jue Yang, et al.. (2012). Diagnosis and Surgical Treatment of Mucin-Producing Bile Duct Tumors. Hepatogastroenterology. 59(120). 2432–5. 1 indexed citations

19.

Jankowski, Janusz, Hugh Barr, Kui Wang, & Brendan Delaney. (2010). Diagnosis and management of Barrett's oesophagus. BMJ. 341(sep10 1). c4551–c4551. 36 indexed citations

20.

Jancey, Jonine, Andy Lee, Peter Howat, et al.. (2007). Reducing Attrition in Physical Activity Programs for Older Adults. Journal of Aging and Physical Activity. 15(2). 152–165. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact